drugset / Trial / NCT00548912
Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
NaSingle-groupOpen-labelTreatment
Summary
The hypothesis of this trial is to assess the effect of spironolactone on heart size and mass
Timeline
- Start
- 2007-10
- Primary completion
- 2008-10
- Completion
- 2008-10
Outcome
Outcome not reported
Stopped: “study ended”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spironolactone | Small molecule | — | — |